RxDoctor Payments Data

Ron Jacob, MD

Cardiovascular Disease · York, PANPI 1639340722

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Canon Medical Systems USA, Inc. at 37.1% of the total. 2025 is the largest year on record at $7,854, 2.7 times the $2,926 reported in 2019. Among cardiovascular disease clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,892in general payments, 2019–2025

Across 66 payments — averaging $301.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Canon Medical Systems USA, Inc.$7K
  • Siemens Medical Solutions USA, Inc.$7K
  • Heartflow, Inc.$2K
  • Abbott$1K
  • Edwards Lifesciences$1K
  • Boston Scientific$158
  • plus $176 from 2 others
$31,850in research payments, 2019–2025

Across 13 payments — averaging $2450.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Heartflow, Inc.$32K

What the payments were for

  • Consulting fees$1,5008%
  • Speaking & faculty fees$9,76649%
  • Travel & lodging$6,16531%
  • Food & beverage$2,46112%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,892 in reported general payments places this provider in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.

See all cardiovascular disease providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$67,355
Medicare patients
673
Services billed
972

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in York

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →